Compare · CHE vs TOI
CHE vs TOI
Side-by-side comparison of Chemed Corp (CHE) and The Oncology Institute Inc. (TOI): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both CHE and TOI operate in Medical/Nursing Services (Health Care), so they compete in similar markets.
- CHE is the larger of the two at $7.11B, about 13.9x TOI ($512.9M).
- Both names hit the wire about 7 times in the past 4 weeks.
- TOI has more recent analyst coverage (8 ratings vs 6 for CHE).
- Company
- Chemed Corp
- The Oncology Institute Inc.
- Price
- $545.01+0.91%
- $5.12+5.13%
- Market cap
- $7.11B
- $512.9M
- 1M return
- +7.23%
- -
- 1Y return
- +22.02%
- -
- Industry
- Medical/Nursing Services
- Medical/Nursing Services
- Exchange
- NYSE
- NASDAQ
- IPO
- 2020
- News (4w)
- 7
- 7
- Recent ratings
- 6
- 8
Chemed Corp
Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers in the United States. It operates in two segments, VITAS and Roto-Rooter. The company also offers plumbing, drain cleaning, water restoration, and other related services to residential and commercial customers through company-owned branches and independent contractors, and franchised locations. Chemed Corporation was incorporated in 1970 and is headquartered in Cincinnati, Ohio.
The Oncology Institute Inc.
The Oncology Institute, Inc. provides cancer awareness, prevention, diagnosis, treatment, and education service. The company offers chemotherapy education, comprehensive lab testing, pain management, financial counseling, end of life counseling, dietary counseling, in-house infusion center, in-house support groups, in-house pharmacy, nutraceuticals, clinical trials, and educational seminars. It also operates the hope, health, and healing center to offer patients alternative and holistic treatments in addition to chemotherapy. The Oncology Institute, Inc. was founded in 2007 and is based in Cerritos, California.
Latest CHE
- Executive vice president Lee Spencer S sold $541,040 worth of Capital Stock (1,000 units at $541.04), decreasing direct ownership by 7% to 13,912 units (SEC Form 4)
- President and CEO Mcnamara Kevin J sold $1,082,320 worth of Capital Stock (2,000 units at $541.16), decreasing direct ownership by 3% to 70,418 units (SEC Form 4)
- VP and Chief Legal Officer Judkins Brian C exercised 6,786 units of Capital Stock at a strike of $445.35 and covered exercise/tax liability with 5,878 units of Capital Stock, increasing direct ownership by 37% to 3,344 units (SEC Form 4)
- CEO - Vitas Healthcare Wherley Joel L exercised 2,599 units of Capital Stock at a strike of $445.35 and covered exercise/tax liability with 2,270 units of Capital Stock, increasing direct ownership by 39% to 1,181 units (SEC Form 4)
- Chemed Corporation Declares Quarterly Dividend of 70 Cents
- President and CEO Mcnamara Kevin J covered exercise/tax liability with 19,802 units of Capital Stock, sold $1,079,020 worth of Capital Stock (2,000 units at $539.51) and exercised 2,001 units of Capital Stock at a strike of $445.35, decreasing direct ownership by 22% to 70,418 units (SEC Form 4)
- Director Grace Patrick P sold $101,080 worth of Capital Stock (190 units at $532.00), decreasing direct ownership by 5% to 3,533 units (SEC Form 4)
- SEC Form 10-Q filed by Chemed Corp
- Chemed Corp filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
- Chemed Reports Second-Quarter 2026 Results
Latest TOI
- Director Hively Brad sold $1,946,310 worth of shares (298,853 units at $6.51), decreasing direct ownership by 42% to 411,976 units (SEC Form 4)
- The Oncology Institute Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation, Financial Statements and Exhibits
- Large owner Chernett Jorey bought $78,480 worth of shares (12,000 units at $6.54), increasing direct ownership by 0.11% to 10,660,858 units (SEC Form 4)
- SEC Form 10-Q filed by The Oncology Institute Inc.
- The Oncology Institute Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
- The Oncology Institute Inc. filed SEC Form 8-K: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Regulation FD Disclosure, Financial Statements and Exhibits
- The Oncology Institute Rebrands as Starling Oncology
- Director Kaushal Mohit was granted 33,133 shares, increasing direct ownership by 19% to 205,716 units (SEC Form 4)
- Director Mcgeorge Anne was granted 41,165 shares, increasing direct ownership by 14% to 332,535 units (SEC Form 4)
- Director Pacala Mark L was granted 30,120 shares, increasing direct ownership by 12% to 286,881 units (SEC Form 4)